FR2447379A1 - Trans-5-aryl-2,3,4,4a-5-9b-hexahydro-1h-pyrido (4,3-b) -indoles substitues en position 2 dextrogyres, procedes et composes intermediaires permettant de les obtenir et composition pharmaceutique les contenant - Google Patents

Trans-5-aryl-2,3,4,4a-5-9b-hexahydro-1h-pyrido (4,3-b) -indoles substitues en position 2 dextrogyres, procedes et composes intermediaires permettant de les obtenir et composition pharmaceutique les contenant

Info

Publication number
FR2447379A1
FR2447379A1 FR8001301A FR8001301A FR2447379A1 FR 2447379 A1 FR2447379 A1 FR 2447379A1 FR 8001301 A FR8001301 A FR 8001301A FR 8001301 A FR8001301 A FR 8001301A FR 2447379 A1 FR2447379 A1 FR 2447379A1
Authority
FR
France
Prior art keywords
dextrogyres
pyrido
hexahydro
trans
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8001301A
Other languages
English (en)
French (fr)
Other versions
FR2447379B1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of FR2447379A1 publication Critical patent/FR2447379A1/fr
Application granted granted Critical
Publication of FR2447379B1 publication Critical patent/FR2447379B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/09—Preparation of carboxylic acids or their salts, halides or anhydrides from carboxylic acid esters or lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42—Separation; Purification; Stabilisation; Use of additives
    • C07C51/487—Separation; Purification; Stabilisation; Use of additives by treatment giving rise to chemical modification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/20—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Anesthesiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
FR8001301A 1979-01-23 1980-01-22 Trans-5-aryl-2,3,4,4a-5-9b-hexahydro-1h-pyrido (4,3-b) -indoles substitues en position 2 dextrogyres, procedes et composes intermediaires permettant de les obtenir et composition pharmaceutique les contenant Granted FR2447379A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/005,698 US4224329A (en) 1979-01-23 1979-01-23 2-Substituted-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indoles

Publications (2)

Publication Number Publication Date
FR2447379A1 true FR2447379A1 (fr) 1980-08-22
FR2447379B1 FR2447379B1 (enExample) 1983-08-19

Family

ID=21717248

Family Applications (3)

Application Number Title Priority Date Filing Date
FR8001301A Granted FR2447379A1 (fr) 1979-01-23 1980-01-22 Trans-5-aryl-2,3,4,4a-5-9b-hexahydro-1h-pyrido (4,3-b) -indoles substitues en position 2 dextrogyres, procedes et composes intermediaires permettant de les obtenir et composition pharmaceutique les contenant
FR8011815A Granted FR2453174A1 (fr) 1979-01-23 1980-05-28 Trans-5-aryl-2,3,4,4a-5-9b-hexahydro-1h-pyrido-(4,3-b)-indoles substitues en position 2. procedes et composes intermediaires permettant de les obtenir et composition pharmaceutique les contenant.
FR8011816A Granted FR2453175A1 (fr) 1979-01-23 1980-05-28 Trans-5-aryl-2,3,4,4a-5-9b-hexahydro-1h-pyrido(4,3-b)-indoles dextrogyres

Family Applications After (2)

Application Number Title Priority Date Filing Date
FR8011815A Granted FR2453174A1 (fr) 1979-01-23 1980-05-28 Trans-5-aryl-2,3,4,4a-5-9b-hexahydro-1h-pyrido-(4,3-b)-indoles substitues en position 2. procedes et composes intermediaires permettant de les obtenir et composition pharmaceutique les contenant.
FR8011816A Granted FR2453175A1 (fr) 1979-01-23 1980-05-28 Trans-5-aryl-2,3,4,4a-5-9b-hexahydro-1h-pyrido(4,3-b)-indoles dextrogyres

Country Status (34)

Country Link
US (1) US4224329A (enExample)
JP (4) JPS55100386A (enExample)
KR (1) KR830001932A (enExample)
AR (1) AR231291A1 (enExample)
AT (1) AT376674B (enExample)
AU (1) AU521986B2 (enExample)
BE (1) BE881283A (enExample)
CA (1) CA1144168A (enExample)
CH (2) CH651040A5 (enExample)
CS (4) CS221806B2 (enExample)
DD (2) DD149071A5 (enExample)
DE (1) DE3002367A1 (enExample)
DK (1) DK25580A (enExample)
EG (1) EG14767A (enExample)
FI (1) FI800179A7 (enExample)
FR (3) FR2447379A1 (enExample)
GB (1) GB2041925B (enExample)
GR (1) GR73567B (enExample)
HU (3) HU189174B (enExample)
IE (1) IE49500B1 (enExample)
IL (1) IL59189A (enExample)
IN (1) IN153300B (enExample)
IT (1) IT1149927B (enExample)
LU (1) LU82105A1 (enExample)
NL (1) NL8000385A (enExample)
NO (2) NO151895C (enExample)
NZ (3) NZ197582A (enExample)
PH (4) PH15736A (enExample)
PL (4) PL120774B1 (enExample)
PT (1) PT70724A (enExample)
SE (3) SE441358B (enExample)
SU (3) SU1168094A3 (enExample)
YU (2) YU269379A (enExample)
ZA (1) ZA796374B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4337250A (en) * 1979-07-30 1982-06-29 Pfizer Inc. Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents
US4432978A (en) * 1979-07-30 1984-02-21 Pfizer Inc. Hexahydro-trans-pyridoindole
US4431649A (en) * 1979-07-30 1984-02-14 Pfizer Inc. Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents
US4431646A (en) * 1979-07-30 1984-02-14 Pfizer Inc. Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents
US4427679A (en) 1981-01-16 1984-01-24 Pfizer Inc. Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents
US4467090A (en) * 1982-09-30 1984-08-21 Pfizer Inc. Compound, 8-fluoro-5-(p-fluorophenyl)-2-[4-(p-fluorophenyl)-4-hydroxybutyryl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole
US4477669A (en) * 1982-09-30 1984-10-16 Pfizer Inc. Processes and intermediates useful in the preparation of flutroline
US4451655A (en) * 1982-05-17 1984-05-29 Pfizer Inc. Process for preparing carboline derivatives and compounds used in their preparation
US4698444A (en) * 1982-09-30 1987-10-06 Pfizer Inc. 1,1-bis(p-fluorophenyl)urea
US4568748A (en) * 1982-09-30 1986-02-04 Pfizer Inc. 2-Carbobenzoxy-8-fluoro-5-(p-fluorophenyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole
JPS61248502A (ja) * 1985-04-26 1986-11-05 Pioneer Electronic Corp 磁性材料の接合方法
US4636563A (en) * 1985-09-16 1987-01-13 American Home Products Corporation Antipsychotic γ-carbolines
US4672117A (en) * 1985-09-16 1987-06-09 American Home Products Corporation Antipsychotic gamma-carbolines
US4798896A (en) * 1988-01-19 1989-01-17 American Home Products Corporation Antipsychotic gamma-carboline N-oxides
US5075315A (en) * 1990-05-17 1991-12-24 Mcneilab, Inc. Antipsychotic hexahydro-2H-indeno[1,2-c]pyridine derivatives
JP4717216B2 (ja) * 1998-12-21 2011-07-06 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ α２−アンタゴニストとしてのベンズイソキサゾールおよびフェノン類
RU2329044C1 (ru) * 2006-11-16 2008-07-20 Андрей Александрович Иващенко Лиганды 5-ht6 рецепторов, фармацевтическая композиция, способ ее получения и лекарственное средство

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2822465A1 (de) * 1977-05-23 1978-11-30 Pfizer Trans-2-substituierte-5-aryl- 2,3,4,4a,5,9b-hexahydro-1h-pyrido eckige klammer auf 4,3-b eckige klammer zu -indolderivate und diese enthaltende arzneimittel

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA551241A (en) * 1958-01-07 S. Abbott Leslie Production of substituted piperidines
US3382250A (en) * 1966-12-07 1968-05-07 Abbott Lab Aroylalkyl derivatives of 1, 2, 3, 4-tetrahydro-5h-pyrido[4, 3b]indoles
US3687961A (en) * 1971-05-03 1972-08-29 Abbott Lab 8-fluoro-2-{8 3-(4-fluorophenylanilinopropyl{9 -gamma-carboline
AR205452A1 (es) * 1973-12-06 1976-05-07 Endo Lab Metodo para preparar nuevos trans-2, 3, 4, 4a, 5, 9b-hexahidro-5-fenil-1h-pirido(4,3-b) indoles
JPS50126699A (enExample) * 1974-03-20 1975-10-04
US4001263A (en) * 1974-04-01 1977-01-04 Pfizer Inc. 5-Aryl-1,2,3,4-tetrahydro-γ-carbolines
AR206812A1 (es) * 1974-04-01 1976-08-23 Pfizer Compuestos intermediarios de azaciclo(3,4-a)indoles 4- y 5-fenil substituidos desprovistos de actividad terapeutica
SE7702301L (sv) * 1976-04-08 1977-10-09 Endo Lab Trans-hexahydro-pyrido-indoler

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2822465A1 (de) * 1977-05-23 1978-11-30 Pfizer Trans-2-substituierte-5-aryl- 2,3,4,4a,5,9b-hexahydro-1h-pyrido eckige klammer auf 4,3-b eckige klammer zu -indolderivate und diese enthaltende arzneimittel
FR2392023A1 (fr) * 1977-05-23 1978-12-22 Pfizer Nouveaux trans-5-aryl-2,3,4,4a,5,9,b-hexahydro-1h-pyrido (4,3-b) indoles, leur procede de preparation et composition pharmaceutique les contenant

Also Published As

Publication number Publication date
PH15736A (en) 1983-03-18
FR2453175A1 (fr) 1980-10-31
AR231291A1 (es) 1984-10-31
JPS5855151B2 (ja) 1983-12-08
PL126532B1 (en) 1983-08-31
AU5476580A (en) 1980-07-31
KR830001932A (ko) 1983-05-19
SE8404555D0 (sv) 1984-09-11
SU1333239A3 (ru) 1987-08-23
ZA796374B (en) 1980-11-26
NZ197581A (en) 1984-05-31
JPS5636486A (en) 1981-04-09
JPS5636475A (en) 1981-04-09
SE8404554L (sv) 1984-09-11
JPS5636487A (en) 1981-04-09
IE800121L (en) 1980-07-23
IL59189A (en) 1984-01-31
DD156369A5 (de) 1982-08-18
CS221807B2 (en) 1983-04-29
YU242183A (en) 1984-06-30
NO151895B (no) 1985-03-18
PH15086A (en) 1982-07-02
CH651040A5 (fr) 1985-08-30
SE8404555L (sv) 1984-09-11
CS221808B2 (en) 1983-04-29
IE49500B1 (en) 1985-10-16
ATA33380A (de) 1984-05-15
DD149071A5 (de) 1981-06-24
GB2041925B (en) 1982-10-20
IN153300B (enExample) 1984-06-30
AU521986B2 (en) 1982-05-13
JPS5740151B2 (enExample) 1982-08-25
FR2447379B1 (enExample) 1983-08-19
EG14767A (en) 1985-12-31
DE3002367A1 (de) 1980-07-24
SE441358B (sv) 1985-09-30
NZ197582A (en) 1984-05-31
SU1080746A3 (ru) 1984-03-15
FR2453175B1 (enExample) 1983-07-29
HU189174B (en) 1986-06-30
PT70724A (en) 1980-02-01
FI800179A7 (fi) 1981-01-01
SU1168094A3 (ru) 1985-07-15
NO794317L (no) 1980-07-24
PL120774B1 (en) 1982-03-31
PL126867B1 (en) 1983-09-30
PL126032B1 (en) 1983-07-30
FR2453174A1 (fr) 1980-10-31
NZ192175A (en) 1984-05-31
SE8404554D0 (sv) 1984-09-11
CA1144168A (en) 1983-04-05
GB2041925A (en) 1980-09-17
PL221248A1 (enExample) 1980-12-01
NO843041L (no) 1980-07-24
FR2453174B1 (enExample) 1983-07-29
PH17773A (en) 1984-12-11
LU82105A1 (fr) 1980-08-08
IT8019373A0 (it) 1980-01-22
DK25580A (da) 1980-07-24
YU269379A (en) 1984-04-30
HU184712B (en) 1984-10-29
GR73567B (enExample) 1984-03-16
CS221809B2 (en) 1983-04-29
NL8000385A (nl) 1980-07-25
JPS55100386A (en) 1980-07-31
PH15072A (en) 1982-06-03
IT1149927B (it) 1986-12-10
NO151895C (no) 1985-06-26
CH648314A5 (fr) 1985-03-15
CS221806B2 (en) 1983-04-29
SE8000329L (sv) 1980-07-24
IL59189A0 (en) 1980-05-30
BE881283A (fr) 1980-07-22
AT376674B (de) 1984-12-27
US4224329A (en) 1980-09-23
HU188201B (en) 1986-03-28

Similar Documents

Publication Publication Date Title
BE885812A (fr) Derives d'acides 6beta-hydroxyalkylpenicillaniques, leur procede de production et compositions pharmaceutiques les contenant
TNSN98022A1 (fr) DERIVES DE N-HYDROXY-β-SULFONYLPROPIONAMIDE, PROCEDE POUR LEUR PREPARATION ET COMPOSITIONS PHARMACEUTIQUES LES CONTENANT.
FR2430403A1 (fr) Nouvelles 15-deoxy-16-hydroxy-prostaglandines, leur procede de production et medicament les contenant
FR2409853A1 (fr) Emboutisseuse et procede permettant le remplacement de ses matrices
FR2495154B1 (fr) 5'-aminoalkyl-4', 4, 8-trialkylpsoralenes, leur procede de production et composition pharmaceutique les contenant
FR2394541A1 (fr) Nouveaux hexahydro-1-hydroxy-9-hydroxymethyl-6h-dibenzo-(b,d)pyranes substitues en position 3, leur procede de preparation et composition pharmaceutique les contenant
BE872347A (fr) Amides substitues de l- et dl-phenylglycine, leur procede de production et composition pharmaceutique les contenant
FR2407926A1 (fr) Derives de quinazoline, leur procede de production et composition pharmaceutique les contenant
IL56346A (en) N-substituted omega-aminoalkanoyl-omega-aminoalkanoic acids,process for their production as well as pharmaceutical compositions containing these compounds
FR2453174A1 (fr) Trans-5-aryl-2,3,4,4a-5-9b-hexahydro-1h-pyrido-(4,3-b)-indoles substitues en position 2. procedes et composes intermediaires permettant de les obtenir et composition pharmaceutique les contenant.
FR2572079B1 (fr) Erlose cristallise. procede pour la preparation de l'erlose cristallise, produit ainsi obtenu ainsi qu'un edulcorant le contenant
MA18748A1 (fr) Procede pour la purification de solutions acides contenant des metaux
FR2434162A1 (fr) Nouveaux derives de 4-amino-2-piperidino-quinazoline, leur procede de production et medicament les contenant
FR2469873A1 (fr) Procedes pour traiter la maladie de l'orme subereux, antibiotique et antimycotique pour leur mise en oeuvre et procede pour leur preparation
BE870576A (fr) Nouveaux acides dialkylamino-7 halogeno-6 oxo-4 dihydro-1,4 quinoleine-3 carboxyliques, procede pour leur preparation et compositions les contenant
FR2407929A1 (fr) Nouveaux derives de 4-amino-2-(piperazin-1-yl ou homopiperazin-1-yl)-quinazoline, leur procede de production et composition pharmaceutique les contenant
FR2430947A1 (fr) Nouveaux composes de 2-amino-octahydro-indolo-(2,3-a)-quinazoline, leur procede de production et medicament les contenant
FR2409997A1 (enExample)
FR2510571B1 (fr) Spirothiazolidinedione, son procede de production et preparation pharmaceutique la contenant
FR2444045A1 (fr) Sels d'argent d'acide phosphanilique, leur procede de production, composition antibacterienne les contenant et leur application a l'inhibition de la croissance des bacteries
FR2428630A1 (fr) Derives d'acide 3-amino-2-(5-fluoro- ou 5-methoxy-1h-indol-3-yl)-propanoique, leur procede de production et medicament les contenant
BE864027A (fr) Procede de preparation de l'alpha-2,5,9-trimethylbenzo-(b)-thieno-(2,3,f)-morphane, produit obtenu et composition pharmaceutique le contenant
FR2444670A1 (fr) 4-carbethoxycarbonylaminopyrimidines, leur procede de production et composition pharmaceutique les contenant
BE866745A (fr) Nouveaux derives de phenylglycine, leur procede de preparation et composition pharmaceutique les contenant
BE872023A (fr) Derives de 4-amino-2-piperidinoquinazoline, leur procede de production et composition pharmaceutique les contenant

Legal Events

Date Code Title Description
ST Notification of lapse